Organon & Co. (OGN)
13.79
0.00 (0.00%)
USD |
NYSE |
Oct 08, 11:54
Organon Gross Profit Margin (Quarterly) : 54.36% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.36% |
| March 31, 2026 | 54.11% |
| December 31, 2025 | 50.36% |
| September 30, 2025 | 53.50% |
| June 30, 2025 | 54.83% |
| March 31, 2025 | 55.58% |
| December 31, 2024 | 56.28% |
| September 30, 2024 | 58.34% |
| June 30, 2024 | 58.43% |
| March 31, 2024 | 59.00% |
| December 31, 2023 | 57.26% |
| September 30, 2023 | 59.71% |
| June 30, 2023 | 60.20% |
| Date | Value |
|---|---|
| March 31, 2023 | 62.29% |
| December 31, 2022 | 60.94% |
| September 30, 2022 | 64.15% |
| June 30, 2022 | 62.90% |
| March 31, 2022 | 64.20% |
| December 31, 2021 | 65.09% |
| September 30, 2021 | 61.94% |
| June 30, 2021 | 63.97% |
| March 31, 2021 | 61.57% |
| December 31, 2020 | 64.00% |
| September 30, 2020 | 66.95% |
| June 30, 2020 | 69.99% |
| March 31, 2020 | 69.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | 71.51% |
| Pfizer Inc. | 62.94% |
| Bristol Myers Squibb Co. | 67.95% |
| Harmony Biosciences Holdings, Inc. | 73.53% |
| ANI Pharmaceuticals, Inc. | 54.97% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 24.30% |
| Return on Assets | 1.58% |
| Return on Invested Capital | 2.18% |
| Profit Margin (Quarterly) | 6.93% |
| Operating Margin (Quarterly) | 20.73% |
| Return on Net Operating Assets | 2.14% |